InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 322406

Friday, 01/12/2018 11:04:49 PM

Friday, January 12, 2018 11:04:49 PM

Post# of 345846

Think of March 2014 and now realize the Epiontis and Precision For Medicine were collaborating with Peregrine with their technology and ultimately, PFM buys out Epiontis as they were advised by Bird&Bird but who else seen Biomarker data from Sunrise ....




So what do you all think about BIOMARKERS now ?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134747702

CGI’s AntigenID™ identifies neoantigens and neoantigen signatures that accelerate immuno-oncology drug identification, predict patient-specific immune therapy response, and help create personalized immuno-vaccines – the immuno-oncology therapy and drug development market is expected to grow to nearly USD $200 Billion by 2021. [1]
http://www.cancergenetics.com/cancer-genetics-inc-a-leader-in-personalized-medicine-launches-antigenid-solidifying-cgis-position-as-a-precision-oncology-leader-in-the-fast-growing-rapidly/



Quartz Bio

Specialty Modules
Dedicated technologies address any biomarker assay
Biomarkers are the measurable characteristics of an individual—and each is as unique as the person it represents. Moreover, biomarkers not only differ in nature, they differ in the platforms through which they are measured, posing tremendous challenges for researchers trying to compare heterogeneous data within and across heterogeneous populations. QuartzBio solves these challenges by accommodating virtually any type of biomarker data and enabling the management, harmonization, and visualization of data collected from multiple technology platforms—visualized at the click of a mouse.



Biomarker Data Management
Rapidly harmonize more than 10 million data points—then analyze and visualize and share at will

Systems Biology
Integrate data, visualize complex relationships, and obtain contextual knowledge on biological systems

Pathway and network visualizations


Access to integrated databases for contextual knowledge generation (GeneMANIA, KEGG, CIViC, Human Protein Atlas, and NCBI)


Data-driven findings linked to networks, pathways, and chemicals


Visualized relationships in hierarchical biological data (DNA-RNA-protein)

Genomics
Explore the genome, transcriptome, and methylome to uncover novel insights from RNA/DNA-seq, NanoString, and Epiontis ID assays
Visualize machine learning and artificial intelligence applied to genome-wide data

Access dimensionality reduction and evaluation of ancestry (PCA, clustering, 3D plots)

Understand how multimarker molecular signatures can predict clinical outcomes

Decipher UCSC Genome Browser and gene- and variant-level annotations

Integrate standard or custom outputs from bioinformatics workflows (eg, GATK)

Visualize gene regulatory networks

....
....
https://www.quartz.bio/specialty-modules/




Epiontis:

UPCOMING EVENTS

January 30-31, 2018, San Diego, CA

Ulrich Hoffmüller, PhD, MBA, VP, Immune Monitoring Solutions and Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, will attend the 6th ImmunoTX Summit by GTCbio

Ulrich Hoffmueller
Vice President, Immune Monitoring Solutions
Epiontis, Precision for Medicine
Advancing the Development of Personalized and Targeted Immune Therapies Utilizing CGI's AntigenID™


Link: https://www.gtcbio.com/conferences/immunotx-summit-agenda



March 8-9, 2018, London, UK

9th Molecular Immunology & Immunogenetics Congress

Link: https://molecularimmunology.conferenceseries.com/



March 27-28, 2018, San Diego, CA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, will attend the Biomarker Summit 2018 by GTCbio

Link: https://www.gtcbio.com/conferences/biomarkers-summit-agenda



April 14-18, 2018, Chicago, IL

AACR Annual Meeting 2018

Link: https://www.asco.org/2018-asco-annual-meeting



May 4-8, 2018, Austin, Texas

Immunology 2018 AAI Annual Meeting

Link: http://www.immunology2018.org/



May 22-24, 2018, Lisbon, Portugal

Biomarkers for Immunotherapy Conference as part of the Molecular Diagnostocs Europe

Link: http://www.moleculardxeurope.com



June 1-5, 2018, Chicago, IL

2018 Asco Annual Meeting

Link: http://am.asco.org



June 18-21, 2018, Boston, MA

17th World Clinical Congress

Link: http://www.worldpreclinicalcongress.com/



June 25-26, 2018, Boston, MA

Ulrich Hoffmüller, PhD, MBA, VP, Immune Monitoring Solutions, Epiontis, will attend the 6th Antibody & Protein Therapeutics Summit

Link: https://www.gtcbio.com/conferences/antibody-protein-therapeutics-summit/



August 28-29, 2018, San Diego, CA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, will attend the 7th Cancer Therapeutics & Partnering Summit by GTCbio

Link: https://www.gtcbio.com/conferences/novel-cancer-therapeutics-summit/



October 19-23, 2018, Munich, Germany

ESMO 2018 Congress

Link: http://www.esmo.org/Conferences/ESMO-2018-Congress



October 24-27, 2018, Lisbon, Portugal

18th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2018)

Link: http://www.esid.kenes.com/2018



November 7-11, 2018, DC

SITC

Link: http://www.sitcancer.org/education/annualmeeting



November 15-16, 2018, Berlin, Germany

7th Biomarker Europe Summit by GTCbio

Link: https://www.gtcbio.com/conferences/7th-biomarker-europe-summit/


http://www.epiontis.com/events/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News